Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone

• Status: Completed
• Trial end date: 2008-07-22
• Target enrollment: 0
• Participant gender: All

Summary

A study to evaluate the effect of SB-656933-AAA on the body after a single dose in subjects who have been challenged with ozone.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: GlaxoSmithKline

Criteria

Inclusion Criteria:

• Healthy subjects between 18-50 years.

• Females should be of non-child bearing potential.

• Non-smoking for at least 12 months.

• Normal lung function.

• Subjects should be able to produce acceptable sputum samples.

Exclusion Criteria:

• Any serious medical condition.

• Hepatitis B or C and/or HIV positive.

• Currently on regular medication except paracetamol.

• Body Mass Index <20 or >30.